What is RGEN's five-year median EV/EBITDA?

61.7x. Half of RGEN's weekly readings over the last five years were higher and half were lower. This page has 755 weekly readings, from May 7, 2012 to Oct 19, 2026.

Does a low historical rank mean a stock is a buy?

No. The rank compares RGEN only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Repligen Corp (RGEN) valuation history

Health Care

$176.93

Latest weekly close · Market cap $10.0B

Within its usual range

As of Oct 24, 2026

RGEN's EV/EBITDA of 68.1x is higher than 55% of its weekly readings over the last five years.

Weekly EV/EBITDA with its 5-year range

EV/EBITDA each weekMiddle half of the last 5 years5-year median 61.7×

5-year median: 61.7×
10-year median: 69.4×
5-year low to high: 29.4×–216.1×
Versus 5-year median: +10%

EV/EBITDA

55thpercentile

of its weekly readings over the last five years

Within its usual range

Growth, last 12 months vs the year before

Revenue: +16%accelerating
EPS: n/a

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends.

PriceRevenue, last 12 monthsEPS, last 12 months100 = first reading

EV/EBITDA at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

RGEN EV/EBITDA at each year-end
Year-end	EV/EBITDA	5-year percentile
Dec 29, 2025	111.7×	81
Dec 30, 2024	101.9×	78
Dec 25, 2023	56.6×	39
Dec 26, 2022	35.0×	2
Dec 27, 2021	80.0×	61
Dec 28, 2020	118.3×	96
Dec 30, 2019	79.6×	90
Dec 31, 2018	57.4×	61
Dec 25, 2017	64.4×	89
Dec 26, 2016	49.9×	75

Health Care peers on EV/EBITDA

Each percentile compares a stock with its own last five years.

Compare RGEN with peers

Health Care peers of RGEN on EV/EBITDA
Stock	EV/EBITDA	Versus its own history	5-year percentile
AAgilent Technologies	26.9×	Historically high	91
AVTRAvantor Inc	128.7×	Historically high	100
BIOBio-Rad Laboratories Inc	n/a	Not ranked	n/a, not ranked
BRKRBruker Corp	52.1×	Historically high	97
CRLCharles River Laboratories	48.3×	Historically high	100

Appears in

Sector: Health Care
Screens: Stocks with Low P/E Ratios and Steady Revenue Growth
Stocks Below Their 5-Year Median P/E
Stocks Near Their Lowest P/E Ratios in 5 Years

Screen Health Care stocks the same way

Research on RGEN

No articles about RGEN yet. How valuation percentiles work

Loading peers and related research…

About this history

What is RGEN's current EV/EBITDA?: RGEN's EV/EBITDA of 68.1x is higher than 55% of its weekly readings over the last five years.
What is RGEN's five-year median EV/EBITDA?: 61.7x. Half of RGEN's weekly readings over the last five years were higher and half were lower. This page has 755 weekly readings, from May 7, 2012 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?: No. The rank compares RGEN only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.